Clinical Evaluation of Nigella Sativa Seeds for the Treatment of Hyperlipidemia: a Randomized, Placebo Controlled Clinical Trial - Zdravlje, medicina, lijecenje, zdravstveni portal

Clinical Evaluation of Nigella Sativa Seeds for the Treatment of Hyperlipidemia: a Randomized, Placebo Controlled Clinical Trial

Clinical Evaluation of Nigella Sativa Seeds for the Treatment of Hyperlipidemia: a Randomized, Placebo Controlled Clinical Trial
Ali Mohammad Sabzghabaee, Mehrnoush Dianatkhah, Nizal Sarrafzadegan, Sedigheh Asgary, Alireza Ghannadi
Med Arh. 2012; 66(3): 198-200

View PDF Fulltext

Abstract

Background: Natural products are proved to play a good role as an alternative to synthetic chemicals in many clinical conditions. Hypercholesterolemia is the most important risk factor for atherosclerosis. Previous studies showed that Nigella sativa L. has both antioxidant and lipid lowering potentials. The aim of this study was to evaluate the efficacy of the seeds of Nigella sativa on the treatment of hyperlipidemia. Methods: In this randomized, placebo controlled clinical trial which was conducted in Isfahan city (Iran), 88 subjects aged ≥ 18 years with a total cholesterol concentration > 200 mg/dl were included. According to the patients` profiles number, they were randomized to receive either N. sativa capsules or the matching placebo. Each N. sativa capsule contained 50010 mg N. sativa crushed seeds, and patients had to take 2 g N. sativa per day for 4 weeks. Fasting baseline laboratory values (Fasting blood sugar, Total cholesterol, Low density lipoprotein, High density lipoprotein and Triglyceride) were obtained for all parameters on each subject prior to the start of the study and at the end of 4 weeks. Results: In our study a significant decrease was observed in the concentration of total cholesterol (4.78%), Low density lipoprotein (7.6%) and Triglyceride (16.65%), and this decrease was more significant for TG concentration. N. sativa had not any beneficial effects on Fasting blood sugar and High density lipoprotein. Conclusion: According to the results of our present study it seems that N. sativa may have some beneficial therapeutic effects in the treatment of hyperlipidemia. However, further investigations with a larger sample size are necessary.

REFERENCES

1. Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia. 1997; 38(Suppl. 11): S6-S8.

2. Leestma JE, Annegers JF, Brodie MJ, Brown S et al. Sudden unexplained death in epilepsy: observations from a large clinical developmental program. Epilepsia. 1997; 38: 47-55.

3. Thomson T, Nashef L, Ryvlin P. Sudden unexpected death in epilepsy: current knowledge and future directions. Lancet Neurology. 2008; 7: 1021-1031.

4. Donner EJ, Smith CR, Snead OC. Sudden unexplained death in children with epilepsy. Neurology. 2001; 57: 430-434.

5. Camfield P, Camfield C. Sudden unexpected death in people with epilepsy. A pediatric perspective. Sem Pediatr Neurol. 2005; 12: 10-14.

6. Weber P, Bubl R, Blauestein U, Tillmann BU et al. Sudden unexplained death in children with epilepsy: a cohort study with an eighteen year follow-up. Acta Paediatr. 2005; 94: 564-567.

7. Geerts A, Arts WF, Stroink H, Peeters E et al. Course and outcome of childhood epilepsy: a 15-year follow-up of the Dutch Study of Epilepsy in Childhood. Epilepsia. 2010; 51: 1189-1197.

8. Gadgil P, Udani V. Pediatric epilepsy: the Indian experience. J Pediatr Neurosci. 2011; 6: S126-129.

9. Terra VC, Scorza FA, Sakamoto AC, Pinto K et al. Does sudden unexpected death in children with epilepsy occur more frequently in those with high seizure frequency? Arq Neuropsiquiatr. 2009; 67(4): 1001-1002.

10. Nilsson L, Farahmand BY, Persson PG, Thiblin I et al. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet. 1999; 353: 888-893.

11. Walczak T. Do antiepileptic drugs play a role in sudden unexpected death in epilepsy? Drug Safety. 2003; 26: 673-683.

12. Appleton RE. Mortality in paediatric epilepsy. Arch Dis Child. 2003; 88: 1091-1094.

13. Pinto K, Scorza FA, Arida RM, Cavalheiro EA. et al. Sudden unexpected death in adolescent with epilepsy: all roads lead to the heart? Cardiology Journal. 2010; 17(X): 1-3.

14. Tavee J, Morris H. Severe postictal laryngospasm as a potential mechanism for sudden unexpected death in epilepsy: a near-miss in an EMU. Epilepsia. 2008; 49: 2113-2117.

15. Bateman LM, Li CS, Seyal M. Ictal hypoxemia in localization-related epilepsy: analysis of incidence, severity and risk factors. Brain. 2008; 131: 3239-3245.

16. Nilsson L, Bergman U, Diwan V, Farahmand BY et al. Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case-control study. Epilepsia. 2001; 42: 667-673.

17. Timmings PL. Sudden unexpected death in epilepsy: is carbamazepine implicated? Seizure. 1998; 7: 289-291.

18. So EL. Sudden unexplained death in epilepsy: epidemiology and risk factors. Neurology Asia. 2011; 16 (Supplement 1): 47-49.

19. Plato. The Republic. Available at http:www.idph.net/conteudos/ebooks/republic.pdf; pg. 34. (Last accessed 20.11.2011).

20. Sokol DK. How the doctor’s nose has shortened over time; a historical overview of the truth-telling debate in the doctor-patient relationship. Journal of the Royal Society of Medicine. 2006; 99: 632-636.

21. Morton B, Richardson A, Duncan S. Sudden unexpected death in epilepsy (SUDEP): don’t ask, don’t tell? J Neurol Neurosurg Psychiatry. 2006; 77: 199-202.

22. Brodie MJ, Holmes GL. Should all patients be told about sudden unexpected death in epilepsy (SUDEP)? Pros and cons. Epilepsia. 2008; 49(Suppl. 9): 99-101.

23. “Vajtimi i Ajkunës”; [The wailing of Ajkuna]; Albanian version available at http://sq.wikipedia.org/wiki/Eposi_i_kreshnikëve. (Last accessed 24.11.2011).

24. Cushner-Weinstein S, Dassoulas K, Salpekar JA, Henderson SE et al. Parenting stress and childhood epilepsy: the impact of depression, learning and seizure-related factors. Epilepsy and Behavior. 2008; 13: 109-114.

25. Vegni E, Leone D, Canevini MP, Tinuper P et al. Sudden unexpected death in epilepsy (SUDEP): a pilot study on truth telling among Italian epileptologists. Neurol Sci. 2011; 32: 331-335.

26. Patra S, Pemde HK, Singh V, Chandra J et al. Profile of adolescents with severe anemia admitted in a tertiary care hospital in Northern India. Indian J Pediatr. 2011; 78(7): 863-865.

27. Sinani F, Ymaj B, Vyshka G. Overzealous cardiac massage leading to unintentional infant death. BMJ Case Reports. 2011; [DOI via Crossref] [DOI via Crossref]

28. Haruni A, Vyshka G, Tashko V, Haruni M, Shira P. Parental reactions after diagnosing a child with epilepsy. Albanian Medical Review. 2011; 3: 108-133 (Article in Albanian. Available at: http://ishp.gov.al/publikime/revista%203.pdf. Last accessed 10.12.2011).

29. Langan Y, Nashef L, Sander JW. Case-control study of SUDEP. Neurology. 2005; 64: 1131-1133.

30. Nobili L, Proserpio P, Rubboli G, Montano N, Didato G, Tassinari CA. Sudden unexpected death in epilepsy (SUDEP) and sleep. Sleep Med Rev. 2011; 15(4): 237-246.

31. Guilhoto LM, Loddenkemper T, Vendrame M, Bergin A, Bourgeois BF, Kothare SV. Higher evening antiepileptic drug dose for nocturnal and early-morning seizures. Epilepsy Behavior. 2011; 20(2): 334-337.

Leave a reply

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>